UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CA 125: the past and the future

The International journal of biological markers, 1998-10, Vol.13 (4), p.179-187

1998

Volltextzugriff (PDF)

Molecular approaches to personalizing management of ovarian cancer

Annals of oncology, 2011-12, Vol.22 Suppl 8 (Suppl 8), p.viii5-viii15

Bast, Jr, R C

2011

Volltextzugriff (PDF)

Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway

Oncogene, 2016-05, Vol.35 (19), p.2506-2517

2016

Volltextzugriff (PDF)

New tumor markers: CA125 and beyond

International journal of gynecological cancer, 2005-11, Vol.15 (s3), p.274-281

2005

Volltextzugriff (PDF)

Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest

Oncogene, 2012-05, Vol.31 (19), p.2450-2460

2012

Volltextzugriff (PDF)

Increased serum levels of macrophage colony-stimulating factor in ovarian cancer

American journal of obstetrics and gynecology, 1991-10, Vol.165 (4), p.1356-1362

1991

Volltextzugriff (PDF)

The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways

Oncogene, 2012-01, Vol.31 (1), p.68-79

2012

Volltextzugriff (PDF)

Clinical application of oxaliplatin in epithelial ovarian cancer

International journal of gynecological cancer, 2006-09, Vol.16 (5), p.1717-1732

2006

Volltextzugriff (PDF)

Current research and treatment for epithelial ovarian cancer A Position Paper from the Helene Harris Memorial Trust

European journal of cancer (1990), 2003-09, Vol.39 (13), p.1818-1827

2003

Volltextzugriff (PDF)

Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas

European journal of cancer (1990), 1994, Vol.30 (8), p.1096-1099

1994

Volltextzugriff (PDF)

Translational research – traffic on the bridge

Biomedicine & pharmacotherapy, 2001-11, Vol.55 (9), p.565-571

2001

Volltextzugriff (PDF)

Radioiodinated antibody targeting of the HER-2/ neu oncoprotein: effects of labeling method on cellular processing and tissue distribution

Nuclear medicine and biology, 1999-10, Vol.26 (7), p.781-790

1999

Volltextzugriff (PDF)

Erratum to “Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust” [European Journal of Cancer, 39 (2003) 1818–1827]

European journal of cancer (1990), 2004-03, Vol.40 (4), p.628-628

2004

Volltextzugriff (PDF)

Increased serum levels of macrophage colony-stimulating factor in ovarian cancer

American journal of obstetrics and gynecology, 1991-11, Vol.165 (5), p.1356-1362

1991

Volltextzugriff (PDF)

Weekly high-dose paclitaxel(HD-P) has significant antitumor activity in inflammatory breast cancer (IBC)

European journal of cancer (1990), 2001-04, Vol.37, p.S173-S173

2001

Volltextzugriff (PDF)

Expression and amplification of the HER-2/ neu ( c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines

American journal of obstetrics and gynecology, 1991-09, Vol.165 (3), p.640-646

1991

Volltextzugriff (PDF)

Radioiodinated antibody targeting of the HER-2/ neu oncoprotein

Nuclear medicine and biology, 1997-07, Vol.24 (5), p.451-459

1997

Volltextzugriff (PDF)

Clinical and Laboratory Directions for Ovarian Cancer Research

Gynecologic oncology, 1994-12, Vol.55 (3), p.S164-S167

Bast, R.C.

1994

Volltextzugriff (PDF)

The immunobiology and immunotherapy of ovarian cancer

Seminars in oncology, 1991-06, Vol.18 (3), p.270-291

1991

Volltextzugriff (PDF)

Transfection of Ovarian Cancer Cells with Tumor Necrosis Factor-α (TNF-α) Antisense mRNA Abolishes the Proliferative Response to Interleukin-1 (IL-1) but Not TNF-α

Gynecologic oncology, 1994-04, Vol.53 (1), p.59-63

1994

Volltextzugriff (PDF)

Elimination of Clonogenic Burkitt's Lymphoma Cells From Human Bone Marrow Using 4-Hydroperoxycyclophosphamide in Combination With Monoclonal Antibodies and Complement

Blood, 1985-05, Vol.65 (5), p.1064-1070

1985

Volltextzugriff (PDF)

Specificity and Affinity of 26 Monoclonal Antibodies against the CA 125 Antigen: First Report from the ISOBM TD-1 Workshop

Tumor biology, 1996-01, Vol.17 (4), p.196-219

1996

Volltextzugriff (PDF)

Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma

Gynecologic oncology, 1985-09, Vol.22 (1), p.115-120

1985

Volltextzugriff (PDF)

CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer

Gynecologic oncology, 1990-02, Vol.36 (2), p.161-165

1990

Volltextzugriff (PDF)

OVX1 and CEA in patients with colon carcinoma, colon polyps and benign colon disorders

The International journal of biological markers, 1998-07, Vol.13 (3), p.145-149

1998

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(54)
Tagungsberichte
(1)

Sprache

Englisch
(55)
Deutsch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

CA 125: the past and the future

Molecular approaches to personalizing management of ovarian cancer

Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway

New tumor markers: CA125 and beyond

Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest

Increased serum levels of macrophage colony-stimulating factor in ovarian cancer

The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways

Clinical application of oxaliplatin in epithelial ovarian cancer

Current research and treatment for epithelial ovarian cancer A Position Paper from the Helene Harris Memorial Trust

Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas

Translational research – traffic on the bridge

Radioiodinated antibody targeting of the HER-2/ neu oncoprotein: effects of labeling method on cellular processing and tissue distribution

Erratum to “Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust” [European Journal of Cancer, 39 (2003) 1818–1827]

Increased serum levels of macrophage colony-stimulating factor in ovarian cancer

Weekly high-dose paclitaxel(HD-P) has significant antitumor activity in inflammatory breast cancer (IBC)

Expression and amplification of the HER-2/ neu ( c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines

Radioiodinated antibody targeting of the HER-2/ neu oncoprotein

Clinical and Laboratory Directions for Ovarian Cancer Research

The immunobiology and immunotherapy of ovarian cancer

Transfection of Ovarian Cancer Cells with Tumor Necrosis Factor-α (TNF-α) Antisense mRNA Abolishes the Proliferative Response to Interleukin-1 (IL-1) but Not TNF-α

Elimination of Clonogenic Burkitt's Lymphoma Cells From Human Bone Marrow Using 4-Hydroperoxycyclophosphamide in Combination With Monoclonal Antibodies and Complement

Specificity and Affinity of 26 Monoclonal Antibodies against the CA 125 Antigen: First Report from the ISOBM TD-1 Workshop

Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma

CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer

OVX1 and CEA in patients with colon carcinoma, colon polyps and benign colon disorders

Suchergebnisse filtern